Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00928564 · ClinicalTrials.gov registry record · NA

Addition of Pudendal Blocks to Pelvic Floor Physical Therapy for the Treatment of Pelvic Floor Tension Myalgia

A NA study of Pelvic Floor Muscle Spasm, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT00928564: Completed NA study of Pelvic Floor Muscle Spasm, sponsored by University of California, Irvine.

NCT00928564 is a NA study of Pelvic Floor Muscle Spasm that has completed, run by University of California, Irvine. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00928564, a NA study of Pelvic Floor Muscle Spasm, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Pelvic floor tension myalgia (PFTM) is increasingly noted in patients with chronic pelvic pain. Pelvic floor physical therapy is typically utilized and is at times combined with other therapies such as botox injections, trigger point injections or pudendal blocks. The investigators' study will randomize newly diagnosed patients with PFTM to weekly . Final patient assessment will be performed at 6 months to assess durability of response. Primary hypothesis: The addition of pudendal blocks to standard pelvic floor physical therapy will result in lower pain and pelvic floor muscle tension scores, lower baseline vaginal pressure and increase pelvic floor strength. Secondary hypothesis: The addition of pudendal blocks to standard pelvic floor physical therapy will result in a lower pain score in a shorter time frame, resulting in faster progress through physical therapy.

Primary Outcome

10 point likert scale to report pain a score from zero for no pain to ten for the worst possible pain

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Pudendal block

Study Locations (1)

California

  • UCI Women's Healthcare - Orange

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2009-04
Est. Completion 2016-05
Phase NA
University of California, Irvine

368 total trials

What the finished NCT00928564 record still lists

NCT00928564 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Pelvic Floor Muscle Spasm appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00928564 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00928564 about?

NCT00928564 is a clinical study titled "Addition of Pudendal Blocks to Pelvic Floor Physical Therapy for the Treatment of Pelvic Floor Tension Myalgia". Pelvic floor tension myalgia (PFTM) is increasingly noted in patients with chronic pelvic pain. Pelvic floor physical therapy is typically utilized and is at times combined with other therapies such as botox injections, trigger point injections or pudendal blocks. The investigators' study will rando...

What is the current status of trial NCT00928564?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2009-04. Estimated completion is 2016-05.

What conditions does trial NCT00928564 study?

This clinical trial studies the following conditions: Pelvic Floor Muscle Spasm.

What interventions are being tested in trial NCT00928564?

The interventions under investigation include: Placebo (DRUG), Pudendal block (DRUG).

Who is sponsoring clinical trial NCT00928564?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00928564 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT00928564's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00928564, the US trial registry maintained by the National Library of Medicine. NCT00928564 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.